LYRM2 and hepatocellular carcinoma: Second, the tumour microenvironment (e.g., hypoxia) may induce the expression of LYRM2 in HCC cells in control group during the process of in vivo growth and metastasis, potentially diminishing the effects of LYRM2 overexpression.